Overview
- Consolidated net profit rose 19.6% year-on-year to Rs 102 crore as operating revenue increased 20.8% to Rs 2,096 crore in Q2 FY26.
- EBITDA climbed nearly 45% to Rs 415 crore, lifting the EBITDA margin to 19.8% from 16.5% a year earlier.
- India revenue reached Rs 1,230 crore while international revenue was Rs 879.64 crore, and the overseas business reported a Rs 31 crore profit versus a Rs 10 crore loss last year.
- Management said September saw some purchase deferrals due to potential GST changes on prescription eyewear, with demand strengthening in Q3 FY26.
- The November IPO priced at Rs 382–402 per share valued Lenskart near $8 billion, and Ambit Capital has criticized the implied multiples as unwarranted versus peers.